@article{a62b110129924f2685b5a6410c7c7084,
title = "An additional drug repurposing study for hidradenitis suppurativa/acne inversa",
author = "Zouboulis, {C. C.} and B. Readhead and Dudley, {J. T.}",
note = "Funding Information: sources: This work was partially funded by a research grant to C.C.Z. from the German Federal Ministry of Education and Research (BMBF) [Project 0313660 {\textquoteleft}Investigation of gene expression in apocrine glands of patients with acne inversa (hidradenitis suppurativa){\textquoteright}] and Unilever R & D, Port Sunlight, Birmingham, UK.The Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany comprise a healthcare unit of the European Reference Network for Rare and Complex Skin Diseases (ERN Skin). Open access funding enabled and organized by ProjektDEAL.",
year = "2021",
month = apr,
doi = "10.1111/bjd.19627",
language = "English",
volume = "184",
pages = "748--750",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Oxford University Press",
number = "4",
}